Summaries of health policy coverage from major news organizations
Biologics Can Achieve Great Success – But At Great Cost
The Wall Street Journal's Health Blog: Insurers want to know why biologic drugs are so expensive. "UnitedHealth Group's Prescription Solutions unit hosted a roundtable this morning in midtown Manhattan focusing on a topic that's hot right now: the rocketing growth of spending on biologic drugs. This type of drug can cost as much as $1.5 million annually, according to Prescription Solutions CEO Jackie Kosecoff. Their success can be dramatic, sending diseases into remission that just years ago were terminal, but are also extremely difficult for patients and payers to afford" (Johnson, 9/29).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.